Among the Sensex firms, State Bank of India, Maruti Suzuki India, Axis Bank, NTPC, BEL, Adani Ports, Eternal, Sun Pharmaceuticals, Power Grid, ITC, UltraTech Cement, Trent, HCL Technologies, Mahindra & Mahindra, and HDFC Bank were the major gainers. On the other hand, Tata Steel, Tata Consultancy Services, Tech Mahindra, Titan, Bajaj Finserv, Tata Motors, Bharti Airtel and Bajaj Finance were among the laggards.
Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year. While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.
Prof Anantha Chandrakasan has been named Massachusetts Institute of Technology's new provost, the first Indian-American to serve in this leadership role.
The research, published in the journal Scientific Reports, provided the first experimental evidence on the capacity of SARS-CoV-2, the virus that causes COVID-19 disease, to infect and be transmitted by mosquitoes.
In what appears to be an astonishing revelation, a US-based scientist who worked at a controversial research lab in China's Wuhan, has said that Covid-19 was a "man-made virus" that leaked from the facility.
China will carry out major scientific research to enhance its biosecurity science and technological capacity against future infectious diseases, state-run Global Times quoted Xiang as saying.
Xi ordered the military to think about worst-case scenarios, scale up training and battle preparedness, promptly and effectively deal with all sorts of complex situations and resolutely safeguard national sovereignty, security and development interests, state-run Xinhua news agency reported, without mentioning any specific issues that posed a threat to the country.